Global COVID-19 Molecular Diagnostics Market Research Report 2024(Status and Outlook)
Report Overview
COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
This report provides a deep insight into the global COVID-19 Molecular Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global COVID-19 Molecular Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the COVID-19 Molecular Diagnostics market in any manner.
Global COVID-19 Molecular Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
Shanghai ZJ Bio-Tech
Market Segmentation (by Type)
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
Market Segmentation (by Application)
Hospitals
Scientific Research
Biodiagnostics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the COVID-19 Molecular Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
This report provides a deep insight into the global COVID-19 Molecular Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global COVID-19 Molecular Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the COVID-19 Molecular Diagnostics market in any manner.
Global COVID-19 Molecular Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
Shanghai ZJ Bio-Tech
Market Segmentation (by Type)
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
Market Segmentation (by Application)
Hospitals
Scientific Research
Biodiagnostics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the COVID-19 Molecular Diagnostics Market
- Overview of the regional outlook of the COVID-19 Molecular Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the COVID-19 Molecular Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of COVID-19 Molecular Diagnostics
1.2 Key Market Segments
1.2.1 COVID-19 Molecular Diagnostics Segment by Type
1.2.2 COVID-19 Molecular Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 MOLECULAR DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global COVID-19 Molecular Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global COVID-19 Molecular Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global COVID-19 Molecular Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global COVID-19 Molecular Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers COVID-19 Molecular Diagnostics Sales Sites, Area Served, Product Type
3.6 COVID-19 Molecular Diagnostics Market Competitive Situation and Trends
3.6.1 COVID-19 Molecular Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest COVID-19 Molecular Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COVID-19 MOLECULAR DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 COVID-19 Molecular Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 MOLECULAR DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global COVID-19 Molecular Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global COVID-19 Molecular Diagnostics Price by Type (2019-2024)
7 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global COVID-19 Molecular Diagnostics Market Sales by Application (2019-2024)
7.3 Global COVID-19 Molecular Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
8 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global COVID-19 Molecular Diagnostics Sales by Region
8.1.1 Global COVID-19 Molecular Diagnostics Sales by Region
8.1.2 Global COVID-19 Molecular Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America COVID-19 Molecular Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe COVID-19 Molecular Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific COVID-19 Molecular Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America COVID-19 Molecular Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa COVID-19 Molecular Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cellex
9.1.1 Cellex COVID-19 Molecular Diagnostics Basic Information
9.1.2 Cellex COVID-19 Molecular Diagnostics Product Overview
9.1.3 Cellex COVID-19 Molecular Diagnostics Product Market Performance
9.1.4 Cellex Business Overview
9.1.5 Cellex COVID-19 Molecular Diagnostics SWOT Analysis
9.1.6 Cellex Recent Developments
9.2 Abbott
9.2.1 Abbott COVID-19 Molecular Diagnostics Basic Information
9.2.2 Abbott COVID-19 Molecular Diagnostics Product Overview
9.2.3 Abbott COVID-19 Molecular Diagnostics Product Market Performance
9.2.4 Abbott Business Overview
9.2.5 Abbott COVID-19 Molecular Diagnostics SWOT Analysis
9.2.6 Abbott Recent Developments
9.3 Roche
9.3.1 Roche COVID-19 Molecular Diagnostics Basic Information
9.3.2 Roche COVID-19 Molecular Diagnostics Product Overview
9.3.3 Roche COVID-19 Molecular Diagnostics Product Market Performance
9.3.4 Roche COVID-19 Molecular Diagnostics SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 BioMedomics
9.4.1 BioMedomics COVID-19 Molecular Diagnostics Basic Information
9.4.2 BioMedomics COVID-19 Molecular Diagnostics Product Overview
9.4.3 BioMedomics COVID-19 Molecular Diagnostics Product Market Performance
9.4.4 BioMedomics Business Overview
9.4.5 BioMedomics Recent Developments
9.5 BD
9.5.1 BD COVID-19 Molecular Diagnostics Basic Information
9.5.2 BD COVID-19 Molecular Diagnostics Product Overview
9.5.3 BD COVID-19 Molecular Diagnostics Product Market Performance
9.5.4 BD Business Overview
9.5.5 BD Recent Developments
9.6 Henry Schein
9.6.1 Henry Schein COVID-19 Molecular Diagnostics Basic Information
9.6.2 Henry Schein COVID-19 Molecular Diagnostics Product Overview
9.6.3 Henry Schein COVID-19 Molecular Diagnostics Product Market Performance
9.6.4 Henry Schein Business Overview
9.6.5 Henry Schein Recent Developments
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech COVID-19 Molecular Diagnostics Basic Information
9.7.2 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Overview
9.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Market Performance
9.7.4 Safecare Bio-Tech Business Overview
9.7.5 Safecare Bio-Tech Recent Developments
9.8 Thermo Fisher
9.8.1 Thermo Fisher COVID-19 Molecular Diagnostics Basic Information
9.8.2 Thermo Fisher COVID-19 Molecular Diagnostics Product Overview
9.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product Market Performance
9.8.4 Thermo Fisher Business Overview
9.8.5 Thermo Fisher Recent Developments
9.9 Bio-rad
9.9.1 Bio-rad COVID-19 Molecular Diagnostics Basic Information
9.9.2 Bio-rad COVID-19 Molecular Diagnostics Product Overview
9.9.3 Bio-rad COVID-19 Molecular Diagnostics Product Market Performance
9.9.4 Bio-rad Business Overview
9.9.5 Bio-rad Recent Developments
9.10 Agilent
9.10.1 Agilent COVID-19 Molecular Diagnostics Basic Information
9.10.2 Agilent COVID-19 Molecular Diagnostics Product Overview
9.10.3 Agilent COVID-19 Molecular Diagnostics Product Market Performance
9.10.4 Agilent Business Overview
9.10.5 Agilent Recent Developments
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Basic Information
9.11.2 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Market Performance
9.11.4 Ortho Clinical Diagnostics Business Overview
9.11.5 Ortho Clinical Diagnostics Recent Developments
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Basic Information
9.12.2 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Market Performance
9.12.4 Zhejiang Orient Gene Biotech Business Overview
9.12.5 Zhejiang Orient Gene Biotech Recent Developments
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology COVID-19 Molecular Diagnostics Basic Information
9.13.2 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Overview
9.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Market Performance
9.13.4 Innovita Biological Technology Business Overview
9.13.5 Innovita Biological Technology Recent Developments
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Basic Information
9.14.2 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Market Performance
9.14.4 Guangzhou Wondfo Biotech Business Overview
9.14.5 Guangzhou Wondfo Biotech Recent Developments
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Basic Information
9.15.2 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Market Performance
9.15.4 Guangdong Hecin-Scientific Business Overview
9.15.5 Guangdong Hecin-Scientific Recent Developments
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Basic Information
9.16.2 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Market Performance
9.16.4 Dynamiker Biotechnology (Tianjin) Business Overview
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
9.17 ADVAITE
9.17.1 ADVAITE COVID-19 Molecular Diagnostics Basic Information
9.17.2 ADVAITE COVID-19 Molecular Diagnostics Product Overview
9.17.3 ADVAITE COVID-19 Molecular Diagnostics Product Market Performance
9.17.4 ADVAITE Business Overview
9.17.5 ADVAITE Recent Developments
9.18 Mayo Clinic Laboratories
9.18.1 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Basic Information
9.18.2 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Overview
9.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Market Performance
9.18.4 Mayo Clinic Laboratories Business Overview
9.18.5 Mayo Clinic Laboratories Recent Developments
9.19 Chembio Diagnostics
9.19.1 Chembio Diagnostics COVID-19 Molecular Diagnostics Basic Information
9.19.2 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Overview
9.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Market Performance
9.19.4 Chembio Diagnostics Business Overview
9.19.5 Chembio Diagnostics Recent Developments
9.20 Mount Sinai Laboratory
9.20.1 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Basic Information
9.20.2 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Overview
9.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Market Performance
9.20.4 Mount Sinai Laboratory Business Overview
9.20.5 Mount Sinai Laboratory Recent Developments
9.21 QIAGEN
9.21.1 QIAGEN COVID-19 Molecular Diagnostics Basic Information
9.21.2 QIAGEN COVID-19 Molecular Diagnostics Product Overview
9.21.3 QIAGEN COVID-19 Molecular Diagnostics Product Market Performance
9.21.4 QIAGEN Business Overview
9.21.5 QIAGEN Recent Developments
9.22 Bioer
9.22.1 Bioer COVID-19 Molecular Diagnostics Basic Information
9.22.2 Bioer COVID-19 Molecular Diagnostics Product Overview
9.22.3 Bioer COVID-19 Molecular Diagnostics Product Market Performance
9.22.4 Bioer Business Overview
9.22.5 Bioer Recent Developments
9.23 Biosynex
9.23.1 Biosynex COVID-19 Molecular Diagnostics Basic Information
9.23.2 Biosynex COVID-19 Molecular Diagnostics Product Overview
9.23.3 Biosynex COVID-19 Molecular Diagnostics Product Market Performance
9.23.4 Biosynex Business Overview
9.23.5 Biosynex Recent Developments
9.24 Esco
9.24.1 Esco COVID-19 Molecular Diagnostics Basic Information
9.24.2 Esco COVID-19 Molecular Diagnostics Product Overview
9.24.3 Esco COVID-19 Molecular Diagnostics Product Market Performance
9.24.4 Esco Business Overview
9.24.5 Esco Recent Developments
9.25 Analytik Jena
9.25.1 Analytik Jena COVID-19 Molecular Diagnostics Basic Information
9.25.2 Analytik Jena COVID-19 Molecular Diagnostics Product Overview
9.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product Market Performance
9.25.4 Analytik Jena Business Overview
9.25.5 Analytik Jena Recent Developments
9.26 Techne
9.26.1 Techne COVID-19 Molecular Diagnostics Basic Information
9.26.2 Techne COVID-19 Molecular Diagnostics Product Overview
9.26.3 Techne COVID-19 Molecular Diagnostics Product Market Performance
9.26.4 Techne Business Overview
9.26.5 Techne Recent Developments
9.27 Da An Gene
9.27.1 Da An Gene COVID-19 Molecular Diagnostics Basic Information
9.27.2 Da An Gene COVID-19 Molecular Diagnostics Product Overview
9.27.3 Da An Gene COVID-19 Molecular Diagnostics Product Market Performance
9.27.4 Da An Gene Business Overview
9.27.5 Da An Gene Recent Developments
9.28 BGI
9.28.1 BGI COVID-19 Molecular Diagnostics Basic Information
9.28.2 BGI COVID-19 Molecular Diagnostics Product Overview
9.28.3 BGI COVID-19 Molecular Diagnostics Product Market Performance
9.28.4 BGI Business Overview
9.28.5 BGI Recent Developments
9.29 Shanghai ZJ Bio-Tech
9.29.1 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Basic Information
9.29.2 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Overview
9.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Market Performance
9.29.4 Shanghai ZJ Bio-Tech Business Overview
9.29.5 Shanghai ZJ Bio-Tech Recent Developments
10 COVID-19 MOLECULAR DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global COVID-19 Molecular Diagnostics Market Size Forecast
10.2 Global COVID-19 Molecular Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe COVID-19 Molecular Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific COVID-19 Molecular Diagnostics Market Size Forecast by Region
10.2.4 South America COVID-19 Molecular Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of COVID-19 Molecular Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global COVID-19 Molecular Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of COVID-19 Molecular Diagnostics by Type (2025-2030)
11.1.2 Global COVID-19 Molecular Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of COVID-19 Molecular Diagnostics by Type (2025-2030)
11.2 Global COVID-19 Molecular Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global COVID-19 Molecular Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global COVID-19 Molecular Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of COVID-19 Molecular Diagnostics
1.2 Key Market Segments
1.2.1 COVID-19 Molecular Diagnostics Segment by Type
1.2.2 COVID-19 Molecular Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COVID-19 MOLECULAR DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global COVID-19 Molecular Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global COVID-19 Molecular Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COVID-19 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global COVID-19 Molecular Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global COVID-19 Molecular Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers COVID-19 Molecular Diagnostics Sales Sites, Area Served, Product Type
3.6 COVID-19 Molecular Diagnostics Market Competitive Situation and Trends
3.6.1 COVID-19 Molecular Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest COVID-19 Molecular Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 COVID-19 MOLECULAR DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 COVID-19 Molecular Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COVID-19 MOLECULAR DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global COVID-19 Molecular Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global COVID-19 Molecular Diagnostics Price by Type (2019-2024)
7 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global COVID-19 Molecular Diagnostics Market Sales by Application (2019-2024)
7.3 Global COVID-19 Molecular Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
8 COVID-19 MOLECULAR DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global COVID-19 Molecular Diagnostics Sales by Region
8.1.1 Global COVID-19 Molecular Diagnostics Sales by Region
8.1.2 Global COVID-19 Molecular Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America COVID-19 Molecular Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe COVID-19 Molecular Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific COVID-19 Molecular Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America COVID-19 Molecular Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa COVID-19 Molecular Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cellex
9.1.1 Cellex COVID-19 Molecular Diagnostics Basic Information
9.1.2 Cellex COVID-19 Molecular Diagnostics Product Overview
9.1.3 Cellex COVID-19 Molecular Diagnostics Product Market Performance
9.1.4 Cellex Business Overview
9.1.5 Cellex COVID-19 Molecular Diagnostics SWOT Analysis
9.1.6 Cellex Recent Developments
9.2 Abbott
9.2.1 Abbott COVID-19 Molecular Diagnostics Basic Information
9.2.2 Abbott COVID-19 Molecular Diagnostics Product Overview
9.2.3 Abbott COVID-19 Molecular Diagnostics Product Market Performance
9.2.4 Abbott Business Overview
9.2.5 Abbott COVID-19 Molecular Diagnostics SWOT Analysis
9.2.6 Abbott Recent Developments
9.3 Roche
9.3.1 Roche COVID-19 Molecular Diagnostics Basic Information
9.3.2 Roche COVID-19 Molecular Diagnostics Product Overview
9.3.3 Roche COVID-19 Molecular Diagnostics Product Market Performance
9.3.4 Roche COVID-19 Molecular Diagnostics SWOT Analysis
9.3.5 Roche Business Overview
9.3.6 Roche Recent Developments
9.4 BioMedomics
9.4.1 BioMedomics COVID-19 Molecular Diagnostics Basic Information
9.4.2 BioMedomics COVID-19 Molecular Diagnostics Product Overview
9.4.3 BioMedomics COVID-19 Molecular Diagnostics Product Market Performance
9.4.4 BioMedomics Business Overview
9.4.5 BioMedomics Recent Developments
9.5 BD
9.5.1 BD COVID-19 Molecular Diagnostics Basic Information
9.5.2 BD COVID-19 Molecular Diagnostics Product Overview
9.5.3 BD COVID-19 Molecular Diagnostics Product Market Performance
9.5.4 BD Business Overview
9.5.5 BD Recent Developments
9.6 Henry Schein
9.6.1 Henry Schein COVID-19 Molecular Diagnostics Basic Information
9.6.2 Henry Schein COVID-19 Molecular Diagnostics Product Overview
9.6.3 Henry Schein COVID-19 Molecular Diagnostics Product Market Performance
9.6.4 Henry Schein Business Overview
9.6.5 Henry Schein Recent Developments
9.7 Safecare Bio-Tech
9.7.1 Safecare Bio-Tech COVID-19 Molecular Diagnostics Basic Information
9.7.2 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Overview
9.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Market Performance
9.7.4 Safecare Bio-Tech Business Overview
9.7.5 Safecare Bio-Tech Recent Developments
9.8 Thermo Fisher
9.8.1 Thermo Fisher COVID-19 Molecular Diagnostics Basic Information
9.8.2 Thermo Fisher COVID-19 Molecular Diagnostics Product Overview
9.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Product Market Performance
9.8.4 Thermo Fisher Business Overview
9.8.5 Thermo Fisher Recent Developments
9.9 Bio-rad
9.9.1 Bio-rad COVID-19 Molecular Diagnostics Basic Information
9.9.2 Bio-rad COVID-19 Molecular Diagnostics Product Overview
9.9.3 Bio-rad COVID-19 Molecular Diagnostics Product Market Performance
9.9.4 Bio-rad Business Overview
9.9.5 Bio-rad Recent Developments
9.10 Agilent
9.10.1 Agilent COVID-19 Molecular Diagnostics Basic Information
9.10.2 Agilent COVID-19 Molecular Diagnostics Product Overview
9.10.3 Agilent COVID-19 Molecular Diagnostics Product Market Performance
9.10.4 Agilent Business Overview
9.10.5 Agilent Recent Developments
9.11 Ortho Clinical Diagnostics
9.11.1 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Basic Information
9.11.2 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Overview
9.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Market Performance
9.11.4 Ortho Clinical Diagnostics Business Overview
9.11.5 Ortho Clinical Diagnostics Recent Developments
9.12 Zhejiang Orient Gene Biotech
9.12.1 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Basic Information
9.12.2 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Overview
9.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Market Performance
9.12.4 Zhejiang Orient Gene Biotech Business Overview
9.12.5 Zhejiang Orient Gene Biotech Recent Developments
9.13 Innovita Biological Technology
9.13.1 Innovita Biological Technology COVID-19 Molecular Diagnostics Basic Information
9.13.2 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Overview
9.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Product Market Performance
9.13.4 Innovita Biological Technology Business Overview
9.13.5 Innovita Biological Technology Recent Developments
9.14 Guangzhou Wondfo Biotech
9.14.1 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Basic Information
9.14.2 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Overview
9.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Market Performance
9.14.4 Guangzhou Wondfo Biotech Business Overview
9.14.5 Guangzhou Wondfo Biotech Recent Developments
9.15 Guangdong Hecin-Scientific
9.15.1 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Basic Information
9.15.2 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Overview
9.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Market Performance
9.15.4 Guangdong Hecin-Scientific Business Overview
9.15.5 Guangdong Hecin-Scientific Recent Developments
9.16 Dynamiker Biotechnology (Tianjin)
9.16.1 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Basic Information
9.16.2 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Overview
9.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Market Performance
9.16.4 Dynamiker Biotechnology (Tianjin) Business Overview
9.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments
9.17 ADVAITE
9.17.1 ADVAITE COVID-19 Molecular Diagnostics Basic Information
9.17.2 ADVAITE COVID-19 Molecular Diagnostics Product Overview
9.17.3 ADVAITE COVID-19 Molecular Diagnostics Product Market Performance
9.17.4 ADVAITE Business Overview
9.17.5 ADVAITE Recent Developments
9.18 Mayo Clinic Laboratories
9.18.1 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Basic Information
9.18.2 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Overview
9.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Market Performance
9.18.4 Mayo Clinic Laboratories Business Overview
9.18.5 Mayo Clinic Laboratories Recent Developments
9.19 Chembio Diagnostics
9.19.1 Chembio Diagnostics COVID-19 Molecular Diagnostics Basic Information
9.19.2 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Overview
9.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Product Market Performance
9.19.4 Chembio Diagnostics Business Overview
9.19.5 Chembio Diagnostics Recent Developments
9.20 Mount Sinai Laboratory
9.20.1 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Basic Information
9.20.2 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Overview
9.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Market Performance
9.20.4 Mount Sinai Laboratory Business Overview
9.20.5 Mount Sinai Laboratory Recent Developments
9.21 QIAGEN
9.21.1 QIAGEN COVID-19 Molecular Diagnostics Basic Information
9.21.2 QIAGEN COVID-19 Molecular Diagnostics Product Overview
9.21.3 QIAGEN COVID-19 Molecular Diagnostics Product Market Performance
9.21.4 QIAGEN Business Overview
9.21.5 QIAGEN Recent Developments
9.22 Bioer
9.22.1 Bioer COVID-19 Molecular Diagnostics Basic Information
9.22.2 Bioer COVID-19 Molecular Diagnostics Product Overview
9.22.3 Bioer COVID-19 Molecular Diagnostics Product Market Performance
9.22.4 Bioer Business Overview
9.22.5 Bioer Recent Developments
9.23 Biosynex
9.23.1 Biosynex COVID-19 Molecular Diagnostics Basic Information
9.23.2 Biosynex COVID-19 Molecular Diagnostics Product Overview
9.23.3 Biosynex COVID-19 Molecular Diagnostics Product Market Performance
9.23.4 Biosynex Business Overview
9.23.5 Biosynex Recent Developments
9.24 Esco
9.24.1 Esco COVID-19 Molecular Diagnostics Basic Information
9.24.2 Esco COVID-19 Molecular Diagnostics Product Overview
9.24.3 Esco COVID-19 Molecular Diagnostics Product Market Performance
9.24.4 Esco Business Overview
9.24.5 Esco Recent Developments
9.25 Analytik Jena
9.25.1 Analytik Jena COVID-19 Molecular Diagnostics Basic Information
9.25.2 Analytik Jena COVID-19 Molecular Diagnostics Product Overview
9.25.3 Analytik Jena COVID-19 Molecular Diagnostics Product Market Performance
9.25.4 Analytik Jena Business Overview
9.25.5 Analytik Jena Recent Developments
9.26 Techne
9.26.1 Techne COVID-19 Molecular Diagnostics Basic Information
9.26.2 Techne COVID-19 Molecular Diagnostics Product Overview
9.26.3 Techne COVID-19 Molecular Diagnostics Product Market Performance
9.26.4 Techne Business Overview
9.26.5 Techne Recent Developments
9.27 Da An Gene
9.27.1 Da An Gene COVID-19 Molecular Diagnostics Basic Information
9.27.2 Da An Gene COVID-19 Molecular Diagnostics Product Overview
9.27.3 Da An Gene COVID-19 Molecular Diagnostics Product Market Performance
9.27.4 Da An Gene Business Overview
9.27.5 Da An Gene Recent Developments
9.28 BGI
9.28.1 BGI COVID-19 Molecular Diagnostics Basic Information
9.28.2 BGI COVID-19 Molecular Diagnostics Product Overview
9.28.3 BGI COVID-19 Molecular Diagnostics Product Market Performance
9.28.4 BGI Business Overview
9.28.5 BGI Recent Developments
9.29 Shanghai ZJ Bio-Tech
9.29.1 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Basic Information
9.29.2 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Overview
9.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Market Performance
9.29.4 Shanghai ZJ Bio-Tech Business Overview
9.29.5 Shanghai ZJ Bio-Tech Recent Developments
10 COVID-19 MOLECULAR DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global COVID-19 Molecular Diagnostics Market Size Forecast
10.2 Global COVID-19 Molecular Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe COVID-19 Molecular Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific COVID-19 Molecular Diagnostics Market Size Forecast by Region
10.2.4 South America COVID-19 Molecular Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of COVID-19 Molecular Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global COVID-19 Molecular Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of COVID-19 Molecular Diagnostics by Type (2025-2030)
11.1.2 Global COVID-19 Molecular Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of COVID-19 Molecular Diagnostics by Type (2025-2030)
11.2 Global COVID-19 Molecular Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global COVID-19 Molecular Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global COVID-19 Molecular Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. COVID-19 Molecular Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global COVID-19 Molecular Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global COVID-19 Molecular Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global COVID-19 Molecular Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global COVID-19 Molecular Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2022)
Table 10. Global Market COVID-19 Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers COVID-19 Molecular Diagnostics Sales Sites and Area Served
Table 12. Manufacturers COVID-19 Molecular Diagnostics Product Type
Table 13. Global COVID-19 Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of COVID-19 Molecular Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. COVID-19 Molecular Diagnostics Market Challenges
Table 22. Global COVID-19 Molecular Diagnostics Sales by Type (K Units)
Table 23. Global COVID-19 Molecular Diagnostics Market Size by Type (M USD)
Table 24. Global COVID-19 Molecular Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global COVID-19 Molecular Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global COVID-19 Molecular Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global COVID-19 Molecular Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global COVID-19 Molecular Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global COVID-19 Molecular Diagnostics Sales (K Units) by Application
Table 30. Global COVID-19 Molecular Diagnostics Market Size by Application
Table 31. Global COVID-19 Molecular Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global COVID-19 Molecular Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global COVID-19 Molecular Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global COVID-19 Molecular Diagnostics Market Share by Application (2019-2024)
Table 35. Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global COVID-19 Molecular Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Cellex COVID-19 Molecular Diagnostics Basic Information
Table 44. Cellex COVID-19 Molecular Diagnostics Product Overview
Table 45. Cellex COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cellex Business Overview
Table 47. Cellex COVID-19 Molecular Diagnostics SWOT Analysis
Table 48. Cellex Recent Developments
Table 49. Abbott COVID-19 Molecular Diagnostics Basic Information
Table 50. Abbott COVID-19 Molecular Diagnostics Product Overview
Table 51. Abbott COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Business Overview
Table 53. Abbott COVID-19 Molecular Diagnostics SWOT Analysis
Table 54. Abbott Recent Developments
Table 55. Roche COVID-19 Molecular Diagnostics Basic Information
Table 56. Roche COVID-19 Molecular Diagnostics Product Overview
Table 57. Roche COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche COVID-19 Molecular Diagnostics SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. BioMedomics COVID-19 Molecular Diagnostics Basic Information
Table 62. BioMedomics COVID-19 Molecular Diagnostics Product Overview
Table 63. BioMedomics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. BioMedomics Business Overview
Table 65. BioMedomics Recent Developments
Table 66. BD COVID-19 Molecular Diagnostics Basic Information
Table 67. BD COVID-19 Molecular Diagnostics Product Overview
Table 68. BD COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BD Business Overview
Table 70. BD Recent Developments
Table 71. Henry Schein COVID-19 Molecular Diagnostics Basic Information
Table 72. Henry Schein COVID-19 Molecular Diagnostics Product Overview
Table 73. Henry Schein COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Henry Schein Business Overview
Table 75. Henry Schein Recent Developments
Table 76. Safecare Bio-Tech COVID-19 Molecular Diagnostics Basic Information
Table 77. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Overview
Table 78. Safecare Bio-Tech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Safecare Bio-Tech Business Overview
Table 80. Safecare Bio-Tech Recent Developments
Table 81. Thermo Fisher COVID-19 Molecular Diagnostics Basic Information
Table 82. Thermo Fisher COVID-19 Molecular Diagnostics Product Overview
Table 83. Thermo Fisher COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Thermo Fisher Business Overview
Table 85. Thermo Fisher Recent Developments
Table 86. Bio-rad COVID-19 Molecular Diagnostics Basic Information
Table 87. Bio-rad COVID-19 Molecular Diagnostics Product Overview
Table 88. Bio-rad COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bio-rad Business Overview
Table 90. Bio-rad Recent Developments
Table 91. Agilent COVID-19 Molecular Diagnostics Basic Information
Table 92. Agilent COVID-19 Molecular Diagnostics Product Overview
Table 93. Agilent COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Business Overview
Table 95. Agilent Recent Developments
Table 96. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Basic Information
Table 97. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Overview
Table 98. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Ortho Clinical Diagnostics Business Overview
Table 100. Ortho Clinical Diagnostics Recent Developments
Table 101. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Basic Information
Table 102. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Overview
Table 103. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Orient Gene Biotech Business Overview
Table 105. Zhejiang Orient Gene Biotech Recent Developments
Table 106. Innovita Biological Technology COVID-19 Molecular Diagnostics Basic Information
Table 107. Innovita Biological Technology COVID-19 Molecular Diagnostics Product Overview
Table 108. Innovita Biological Technology COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Innovita Biological Technology Business Overview
Table 110. Innovita Biological Technology Recent Developments
Table 111. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Basic Information
Table 112. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Overview
Table 113. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Guangzhou Wondfo Biotech Business Overview
Table 115. Guangzhou Wondfo Biotech Recent Developments
Table 116. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Basic Information
Table 117. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Overview
Table 118. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Guangdong Hecin-Scientific Business Overview
Table 120. Guangdong Hecin-Scientific Recent Developments
Table 121. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Basic Information
Table 122. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Overview
Table 123. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Dynamiker Biotechnology (Tianjin) Business Overview
Table 125. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 126. ADVAITE COVID-19 Molecular Diagnostics Basic Information
Table 127. ADVAITE COVID-19 Molecular Diagnostics Product Overview
Table 128. ADVAITE COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. ADVAITE Business Overview
Table 130. ADVAITE Recent Developments
Table 131. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Basic Information
Table 132. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Overview
Table 133. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Mayo Clinic Laboratories Business Overview
Table 135. Mayo Clinic Laboratories Recent Developments
Table 136. Chembio Diagnostics COVID-19 Molecular Diagnostics Basic Information
Table 137. Chembio Diagnostics COVID-19 Molecular Diagnostics Product Overview
Table 138. Chembio Diagnostics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Chembio Diagnostics Business Overview
Table 140. Chembio Diagnostics Recent Developments
Table 141. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Basic Information
Table 142. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Overview
Table 143. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Mount Sinai Laboratory Business Overview
Table 145. Mount Sinai Laboratory Recent Developments
Table 146. QIAGEN COVID-19 Molecular Diagnostics Basic Information
Table 147. QIAGEN COVID-19 Molecular Diagnostics Product Overview
Table 148. QIAGEN COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. QIAGEN Business Overview
Table 150. QIAGEN Recent Developments
Table 151. Bioer COVID-19 Molecular Diagnostics Basic Information
Table 152. Bioer COVID-19 Molecular Diagnostics Product Overview
Table 153. Bioer COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Bioer Business Overview
Table 155. Bioer Recent Developments
Table 156. Biosynex COVID-19 Molecular Diagnostics Basic Information
Table 157. Biosynex COVID-19 Molecular Diagnostics Product Overview
Table 158. Biosynex COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Biosynex Business Overview
Table 160. Biosynex Recent Developments
Table 161. Esco COVID-19 Molecular Diagnostics Basic Information
Table 162. Esco COVID-19 Molecular Diagnostics Product Overview
Table 163. Esco COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Esco Business Overview
Table 165. Esco Recent Developments
Table 166. Analytik Jena COVID-19 Molecular Diagnostics Basic Information
Table 167. Analytik Jena COVID-19 Molecular Diagnostics Product Overview
Table 168. Analytik Jena COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Analytik Jena Business Overview
Table 170. Analytik Jena Recent Developments
Table 171. Techne COVID-19 Molecular Diagnostics Basic Information
Table 172. Techne COVID-19 Molecular Diagnostics Product Overview
Table 173. Techne COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Techne Business Overview
Table 175. Techne Recent Developments
Table 176. Da An Gene COVID-19 Molecular Diagnostics Basic Information
Table 177. Da An Gene COVID-19 Molecular Diagnostics Product Overview
Table 178. Da An Gene COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Da An Gene Business Overview
Table 180. Da An Gene Recent Developments
Table 181. BGI COVID-19 Molecular Diagnostics Basic Information
Table 182. BGI COVID-19 Molecular Diagnostics Product Overview
Table 183. BGI COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. BGI Business Overview
Table 185. BGI Recent Developments
Table 186. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Basic Information
Table 187. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Overview
Table 188. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. Shanghai ZJ Bio-Tech Business Overview
Table 190. Shanghai ZJ Bio-Tech Recent Developments
Table 191. Global COVID-19 Molecular Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 192. Global COVID-19 Molecular Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 193. North America COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 194. North America COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 195. Europe COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 196. Europe COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 197. Asia Pacific COVID-19 Molecular Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 198. Asia Pacific COVID-19 Molecular Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 199. South America COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 200. South America COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 201. Middle East and Africa COVID-19 Molecular Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 202. Middle East and Africa COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 203. Global COVID-19 Molecular Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 204. Global COVID-19 Molecular Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 205. Global COVID-19 Molecular Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 206. Global COVID-19 Molecular Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 207. Global COVID-19 Molecular Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. COVID-19 Molecular Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global COVID-19 Molecular Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global COVID-19 Molecular Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global COVID-19 Molecular Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global COVID-19 Molecular Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2022)
Table 10. Global Market COVID-19 Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers COVID-19 Molecular Diagnostics Sales Sites and Area Served
Table 12. Manufacturers COVID-19 Molecular Diagnostics Product Type
Table 13. Global COVID-19 Molecular Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of COVID-19 Molecular Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. COVID-19 Molecular Diagnostics Market Challenges
Table 22. Global COVID-19 Molecular Diagnostics Sales by Type (K Units)
Table 23. Global COVID-19 Molecular Diagnostics Market Size by Type (M USD)
Table 24. Global COVID-19 Molecular Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global COVID-19 Molecular Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global COVID-19 Molecular Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global COVID-19 Molecular Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global COVID-19 Molecular Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global COVID-19 Molecular Diagnostics Sales (K Units) by Application
Table 30. Global COVID-19 Molecular Diagnostics Market Size by Application
Table 31. Global COVID-19 Molecular Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global COVID-19 Molecular Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global COVID-19 Molecular Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global COVID-19 Molecular Diagnostics Market Share by Application (2019-2024)
Table 35. Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global COVID-19 Molecular Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America COVID-19 Molecular Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa COVID-19 Molecular Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Cellex COVID-19 Molecular Diagnostics Basic Information
Table 44. Cellex COVID-19 Molecular Diagnostics Product Overview
Table 45. Cellex COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cellex Business Overview
Table 47. Cellex COVID-19 Molecular Diagnostics SWOT Analysis
Table 48. Cellex Recent Developments
Table 49. Abbott COVID-19 Molecular Diagnostics Basic Information
Table 50. Abbott COVID-19 Molecular Diagnostics Product Overview
Table 51. Abbott COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Abbott Business Overview
Table 53. Abbott COVID-19 Molecular Diagnostics SWOT Analysis
Table 54. Abbott Recent Developments
Table 55. Roche COVID-19 Molecular Diagnostics Basic Information
Table 56. Roche COVID-19 Molecular Diagnostics Product Overview
Table 57. Roche COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Roche COVID-19 Molecular Diagnostics SWOT Analysis
Table 59. Roche Business Overview
Table 60. Roche Recent Developments
Table 61. BioMedomics COVID-19 Molecular Diagnostics Basic Information
Table 62. BioMedomics COVID-19 Molecular Diagnostics Product Overview
Table 63. BioMedomics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. BioMedomics Business Overview
Table 65. BioMedomics Recent Developments
Table 66. BD COVID-19 Molecular Diagnostics Basic Information
Table 67. BD COVID-19 Molecular Diagnostics Product Overview
Table 68. BD COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. BD Business Overview
Table 70. BD Recent Developments
Table 71. Henry Schein COVID-19 Molecular Diagnostics Basic Information
Table 72. Henry Schein COVID-19 Molecular Diagnostics Product Overview
Table 73. Henry Schein COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Henry Schein Business Overview
Table 75. Henry Schein Recent Developments
Table 76. Safecare Bio-Tech COVID-19 Molecular Diagnostics Basic Information
Table 77. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Overview
Table 78. Safecare Bio-Tech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Safecare Bio-Tech Business Overview
Table 80. Safecare Bio-Tech Recent Developments
Table 81. Thermo Fisher COVID-19 Molecular Diagnostics Basic Information
Table 82. Thermo Fisher COVID-19 Molecular Diagnostics Product Overview
Table 83. Thermo Fisher COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Thermo Fisher Business Overview
Table 85. Thermo Fisher Recent Developments
Table 86. Bio-rad COVID-19 Molecular Diagnostics Basic Information
Table 87. Bio-rad COVID-19 Molecular Diagnostics Product Overview
Table 88. Bio-rad COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Bio-rad Business Overview
Table 90. Bio-rad Recent Developments
Table 91. Agilent COVID-19 Molecular Diagnostics Basic Information
Table 92. Agilent COVID-19 Molecular Diagnostics Product Overview
Table 93. Agilent COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Agilent Business Overview
Table 95. Agilent Recent Developments
Table 96. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Basic Information
Table 97. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product Overview
Table 98. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Ortho Clinical Diagnostics Business Overview
Table 100. Ortho Clinical Diagnostics Recent Developments
Table 101. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Basic Information
Table 102. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product Overview
Table 103. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Zhejiang Orient Gene Biotech Business Overview
Table 105. Zhejiang Orient Gene Biotech Recent Developments
Table 106. Innovita Biological Technology COVID-19 Molecular Diagnostics Basic Information
Table 107. Innovita Biological Technology COVID-19 Molecular Diagnostics Product Overview
Table 108. Innovita Biological Technology COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Innovita Biological Technology Business Overview
Table 110. Innovita Biological Technology Recent Developments
Table 111. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Basic Information
Table 112. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product Overview
Table 113. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Guangzhou Wondfo Biotech Business Overview
Table 115. Guangzhou Wondfo Biotech Recent Developments
Table 116. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Basic Information
Table 117. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product Overview
Table 118. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Guangdong Hecin-Scientific Business Overview
Table 120. Guangdong Hecin-Scientific Recent Developments
Table 121. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Basic Information
Table 122. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product Overview
Table 123. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Dynamiker Biotechnology (Tianjin) Business Overview
Table 125. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 126. ADVAITE COVID-19 Molecular Diagnostics Basic Information
Table 127. ADVAITE COVID-19 Molecular Diagnostics Product Overview
Table 128. ADVAITE COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. ADVAITE Business Overview
Table 130. ADVAITE Recent Developments
Table 131. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Basic Information
Table 132. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product Overview
Table 133. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Mayo Clinic Laboratories Business Overview
Table 135. Mayo Clinic Laboratories Recent Developments
Table 136. Chembio Diagnostics COVID-19 Molecular Diagnostics Basic Information
Table 137. Chembio Diagnostics COVID-19 Molecular Diagnostics Product Overview
Table 138. Chembio Diagnostics COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Chembio Diagnostics Business Overview
Table 140. Chembio Diagnostics Recent Developments
Table 141. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Basic Information
Table 142. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product Overview
Table 143. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Mount Sinai Laboratory Business Overview
Table 145. Mount Sinai Laboratory Recent Developments
Table 146. QIAGEN COVID-19 Molecular Diagnostics Basic Information
Table 147. QIAGEN COVID-19 Molecular Diagnostics Product Overview
Table 148. QIAGEN COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. QIAGEN Business Overview
Table 150. QIAGEN Recent Developments
Table 151. Bioer COVID-19 Molecular Diagnostics Basic Information
Table 152. Bioer COVID-19 Molecular Diagnostics Product Overview
Table 153. Bioer COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Bioer Business Overview
Table 155. Bioer Recent Developments
Table 156. Biosynex COVID-19 Molecular Diagnostics Basic Information
Table 157. Biosynex COVID-19 Molecular Diagnostics Product Overview
Table 158. Biosynex COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Biosynex Business Overview
Table 160. Biosynex Recent Developments
Table 161. Esco COVID-19 Molecular Diagnostics Basic Information
Table 162. Esco COVID-19 Molecular Diagnostics Product Overview
Table 163. Esco COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Esco Business Overview
Table 165. Esco Recent Developments
Table 166. Analytik Jena COVID-19 Molecular Diagnostics Basic Information
Table 167. Analytik Jena COVID-19 Molecular Diagnostics Product Overview
Table 168. Analytik Jena COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. Analytik Jena Business Overview
Table 170. Analytik Jena Recent Developments
Table 171. Techne COVID-19 Molecular Diagnostics Basic Information
Table 172. Techne COVID-19 Molecular Diagnostics Product Overview
Table 173. Techne COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 174. Techne Business Overview
Table 175. Techne Recent Developments
Table 176. Da An Gene COVID-19 Molecular Diagnostics Basic Information
Table 177. Da An Gene COVID-19 Molecular Diagnostics Product Overview
Table 178. Da An Gene COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 179. Da An Gene Business Overview
Table 180. Da An Gene Recent Developments
Table 181. BGI COVID-19 Molecular Diagnostics Basic Information
Table 182. BGI COVID-19 Molecular Diagnostics Product Overview
Table 183. BGI COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 184. BGI Business Overview
Table 185. BGI Recent Developments
Table 186. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Basic Information
Table 187. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product Overview
Table 188. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 189. Shanghai ZJ Bio-Tech Business Overview
Table 190. Shanghai ZJ Bio-Tech Recent Developments
Table 191. Global COVID-19 Molecular Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 192. Global COVID-19 Molecular Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 193. North America COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 194. North America COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 195. Europe COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 196. Europe COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 197. Asia Pacific COVID-19 Molecular Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 198. Asia Pacific COVID-19 Molecular Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 199. South America COVID-19 Molecular Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 200. South America COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 201. Middle East and Africa COVID-19 Molecular Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 202. Middle East and Africa COVID-19 Molecular Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 203. Global COVID-19 Molecular Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 204. Global COVID-19 Molecular Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 205. Global COVID-19 Molecular Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 206. Global COVID-19 Molecular Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 207. Global COVID-19 Molecular Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of COVID-19 Molecular Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global COVID-19 Molecular Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global COVID-19 Molecular Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global COVID-19 Molecular Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. COVID-19 Molecular Diagnostics Market Size by Country (M USD)
Figure 11. COVID-19 Molecular Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global COVID-19 Molecular Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market COVID-19 Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global COVID-19 Molecular Diagnostics Market Share by Type
Figure 18. Sales Market Share of COVID-19 Molecular Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of COVID-19 Molecular Diagnostics by Type in 2023
Figure 20. Market Size Share of COVID-19 Molecular Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of COVID-19 Molecular Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global COVID-19 Molecular Diagnostics Market Share by Application
Figure 24. Global COVID-19 Molecular Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global COVID-19 Molecular Diagnostics Sales Market Share by Application in 2023
Figure 26. Global COVID-19 Molecular Diagnostics Market Share by Application (2019-2024)
Figure 27. Global COVID-19 Molecular Diagnostics Market Share by Application in 2023
Figure 28. Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global COVID-19 Molecular Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada COVID-19 Molecular Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico COVID-19 Molecular Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific COVID-19 Molecular Diagnostics Sales Market Share by Region in 2023
Figure 44. China COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa COVID-19 Molecular Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global COVID-19 Molecular Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global COVID-19 Molecular Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global COVID-19 Molecular Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global COVID-19 Molecular Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global COVID-19 Molecular Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global COVID-19 Molecular Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of COVID-19 Molecular Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global COVID-19 Molecular Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global COVID-19 Molecular Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global COVID-19 Molecular Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. COVID-19 Molecular Diagnostics Market Size by Country (M USD)
Figure 11. COVID-19 Molecular Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global COVID-19 Molecular Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market COVID-19 Molecular Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global COVID-19 Molecular Diagnostics Market Share by Type
Figure 18. Sales Market Share of COVID-19 Molecular Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of COVID-19 Molecular Diagnostics by Type in 2023
Figure 20. Market Size Share of COVID-19 Molecular Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of COVID-19 Molecular Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global COVID-19 Molecular Diagnostics Market Share by Application
Figure 24. Global COVID-19 Molecular Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global COVID-19 Molecular Diagnostics Sales Market Share by Application in 2023
Figure 26. Global COVID-19 Molecular Diagnostics Market Share by Application (2019-2024)
Figure 27. Global COVID-19 Molecular Diagnostics Market Share by Application in 2023
Figure 28. Global COVID-19 Molecular Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global COVID-19 Molecular Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada COVID-19 Molecular Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico COVID-19 Molecular Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific COVID-19 Molecular Diagnostics Sales Market Share by Region in 2023
Figure 44. China COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America COVID-19 Molecular Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa COVID-19 Molecular Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa COVID-19 Molecular Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa COVID-19 Molecular Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global COVID-19 Molecular Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global COVID-19 Molecular Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global COVID-19 Molecular Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global COVID-19 Molecular Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global COVID-19 Molecular Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global COVID-19 Molecular Diagnostics Market Share Forecast by Application (2025-2030)
